Coming up at The New Health Club
Next week, we’re taking a two week podcast break. Your newsletter will be sent as normal (along with a little surprise - stay tuned!)
Put August 20th in your diaries, as we will launch our YouTube series! So excited for this! Our first guest will be Christian Angermayer, a total driving force and one of the biggest evangelists in modern psychedelics.
On August 27th we come back to you with our full content package: starting with a killer podcast featuring Graham Boyd, the political director of Dr. Bronners. Graham is also the co-founder and Executive Director of Psychedelic Science Funders Collaborative (PSFC). And he’s deeply involved with making MDMA therapy available as soon as possible.
Now, back to Ibogaine. Wait, what is this?
After weeks of magic mushrooms and LSD, we want to tell you about a new substance called Ibogaine. Ibogaine is a naturally occurring psychoactive substance found in the Apocynaceae plant family which includes Tabernanthe iboga, Voacanga africana, and Tabernaemontana undulata. These days Ibogaine is being used to treat severe drug addiction (including heroin, alcohol, and opioids). But there is still not enough research around this and that’s why Deborah Mash and her company DemeRx are setting up a joint venture with ATAI Life Sciences to research the “neurochemical reset” for people suffering from addictions. Addictions they are struggling to beat and may not beat with the current existing tools.
Podcast
My guest Deborah Mash is one cool research lady from Miami. She’s tough, educated, and all-too familiar with the drug wars in Miami, a series of conflicts that took place between government and cartels during the ‘70s and ‘80s. She knew a Miami that was flooded with cocaine and champagne, resulting in mass addiction problems across society, and who are looking for new tools to beat addiction to this day.
Mash is an American professor of neurology and pharmacology at the Leonard M. Miller School of Medicine, director of the Brain Endowment Bank at the University of Miami, and is the CEO of her company DemeRx.
In the ‘90s, Mash and her team found a third substance that addicts produce if they use alcohol and cocaine at the same time, a molecule that makes addiction impossible to beat. Deborah called it the “Miami Vice Metabolite” and spent a lot of time researching how both the molecule and the resulting addiction could be handled.
I was a little shocked when I heard about the molecule during our conversations, since I feel I knew a lot of people, especially in Berlin who were educated, wealthy and established, but 100% addicted to this molecule and they would not even know about it.
From very early on, Mash was an expert on heavy substance abuse, addiction that was destroying the many people’s lives. Now she’s researching Ibogaine, a natural indole alkaloid derived from the West African iboga plant. In African traditional medicine and rituals, chewing the yellow-coloured root or bark is used to produce hallucinations. Now, Mash and ATAI Life Sciences explore the ibogaine substance as a new mental health drug to beat alcohol, heroin and other opioid addiction.
I know this subject is heavy, but as we speak, the number of people battling addiction is rising.
Of course, the episode is sponsored by Dr. Bronners as part of our special “Heal Soul” series, which is sponsored by Dr. Bronner’s, the activist soap company from California.
Dr. Bronner’s is a family-owned company founded in 1948, that is dedicated to honoring the vision of its founder, Emanuel Bronner, by making personal care products of the highest quality and by dedicating profits to promote a better world for all. The Bronner family started making soap in 1858 here in Germany, and carries on the family soap making tradition today, by using the company as an engine for progressive social change.
I got to know Dr. Bronner’s when I lived in Los Angeles and when I went shopping at Trader Joes, I made sure to pick up some of the delicious peppermint soap that all of us were using. It was just such a California thing, which I loved, but there is more to it.
Dr. Bronner’s dedicates profits to organizations working in support of regenerative organic agriculture, animal rights, community betterment, criminal justice reform, fair pay & and fair trade, and drug policy reform – which includes the responsible and equitable integration of psychedelic medicine into American and Global culture.
For more information on Dr. Bronner’s in Germany, please visit: drbronner.de
For more information on Dr. Bronner’s globally and in the United States, please visit: drbronner.com
And please check out this episode of The New Health Club to hear my interview with CEO David Bronner, and world-renowned psychedelic therapy activist, as we discuss how psychedelics might help to heal Holocaust trauma.
On another note…
This is a really good podcast in german about psychedelic experiences called Set & Setting! I was honoured to be a guest. Please enjoy the the podcast I did with Jascha Renner.
Articles
Global Psychedelic Drugs Market is Likely to Experience a Tremendous Growth in Near Future - Owned.
Drugs like MDMA and LSD are Transforming Therapy - Futurity.
Election 2020: Oregon Psilocybin and Drug Decriminalization Initiatives Guide - Leafly.
MindMed Seeks to Harvest the Power of Psychedelics to Treat Mental Health Disorders - Proactive.
🍄 The New Health Club #28 - Deborah Mash: The time for ibogaine is now.